Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 46
- +2 vs. Q1 2024
- Portfolio value
- $334.6M
- −$24.9M (−6.9%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,349,980 | $33.5M | 10.0% | +418,468+44.9% | Added | History |
| ADCTADC Therapeutics SA | SHS | 9,570,000 | $30.2M | 9.0% | +2,519,700+35.7% | Added | History |
| ROIVRoivant Sciences Ltd. | SHS | 2,000,000 | $21.1M | 6.3% | +140,000+7.5% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 800,000 | $20.3M | 6.1% | +210,470+35.7% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 170,000 | $18.5M | 5.5% | +151,092+799.1% | Added | History |
| MGTXMeiraGTx Holdings plc | COM | 4,352,700 | $18.3M | 5.5% | +335,399+8.3% | Added | History |
| STTKShattuck Labs, Inc. | COM | 4,670,000 | $18.0M | 5.4% | +945,000+25.4% | Added | History |
| KURAKura Oncology, Inc. | COM | 629,900 | $13.0M | 3.9% | −330,100−34.4% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 230,000 | $12.5M | 3.7% | −15,000−6.1% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 551,544 | $11.3M | 3.4% | +551,544 | New | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 314,800 | $10.8M | 3.2% | −150,200−32.3% | Reduced | History |
| KELYAKelly Services Inc | CL A | 492,340 | $10.5M | 3.2% | +143,654+41.2% | Added | History |
| ZYMEZymeworks Inc. | COM | 1,180,000 | $10.0M | 3.0% | +769,052+187.1% | Added | History |
| IMVTImmunovant, Inc. | COM | 325,000 | $8.58M | 2.6% | +130,000+66.7% | Added | History |
| SDGRSchrodinger, Inc. | COM | 369,261 | $7.14M | 2.1% | +369,261 | New | History |
| ABCLAbCellera Biologics Inc. | COM | 2,352,633 | $6.96M | 2.1% | +562,633+31.4% | Added | History |
| ALKSAlkermes plc. | SHS | 275,000 | $6.63M | 2.0% | +60,000+27.9% | Added | History |
| ERASErasca, Inc. | COM | 2,750,000 | $6.49M | 1.9% | −909,755−24.9% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 115,000 | $6.10M | 1.8% | +75,954+194.5% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 286,926 | $5.92M | 1.8% | +116,457+68.3% | Added | History |
| KIDSOrthopediatrics Corp | COM | 200,216 | $5.76M | 1.7% | −218,045−52.1% | Reduced | History |
| OPCHOption Care Health, Inc. | COM NEW | 205,000 | $5.68M | 1.7% | +105,000+105.0% | Added | History |
| DXCMDexcom Inc | COM | 49,317 | $5.59M | 1.7% | +26,317+114.4% | Added | History |
| ACCDAccolade, Inc. | COM | 1,489,525 | $5.33M | 1.6% | +1,489,525 | New | History |
| COGTCogent Biosciences, Inc. | COM | 500,000 | $4.21M | 1.3% | −55,500−10.0% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 27,000 | $3.72M | 1.1% | −3,500−11.5% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 385,000 | $2.51M | 0.8% | −65,000−14.4% | Reduced | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 398,700 | $2.46M | 0.7% | −1,001,300−71.5% | Reduced | History |
| CVSCVS Health Corp | Stock | 40,000 | $2.36M | 0.7% | +40,000 | New | History |
| MDTMedtronic plc | Stock | 30,000 | $2.36M | 0.7% | −150,000−83.3% | Reduced | History |
| VINCVincerx Pharma, Inc. | COM NEW | 2,488,418 | $2.02M | 0.6% | +2,488,418 | New | History |
| INSPInspire Medical Systems, Inc. | COM | 14,000 | $1.87M | 0.6% | +14,000 | New | History |
| FNAParagon 28, Inc. | COM | 261,400 | $1.79M | 0.5% | +261,400 | New | History |
| UHSUniversal Health Services Inc | CL B | 9,373 | $1.73M | 0.5% | −20,627−68.8% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 96,065 | $1.67M | 0.5% | +51,065+113.5% | Added | History |
| MURAMural Oncology plc | ORD SHS | 475,458 | $1.49M | 0.4% | +75,458+18.9% | Added | History |
| ADUSAddus HomeCare Corp | COM | 12,500 | $1.45M | 0.4% | +12,500 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 67,461 | $1.11M | 0.3% | +20,251+42.9% | AddedConverted for a 1-for-12 split | History |
| LENZLENZ Therapeutics, Inc. | COM | 59,542 | $1.03M | 0.3% | −5,458−8.4% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 49,021 | $953.5K | 0.3% | +19,021+63.4% | Added | History |
| OVIDOvid Therapeutics Inc. | COM | 1,075,000 | $826.9K | 0.2% | +91,800+9.3% | Added | History |
| IMNMImmunome Inc. | COM | 65,000 | $786.5K | 0.2% | +65,000 | New | History |
| RNTXRein Therapeutics, Inc. | COM NEW | 265,000 | $734.0K | 0.2% | +265,000 | New | History |
| IMRXImmuneering Corp | CLASS A COM | 550,000 | $704.0K | 0.2% | +550,000 | New | History |
| BMEABiomea Fusion, Inc. | COM | 124,377 | $559.7K | 0.2% | +49,377+65.8% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 56,080 | $33.6K | <0.1% | −907,518−94.2% | Reduced | History |
Sold out since Q1 2024 (9)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| GHGuardant Health, Inc. | COM | 470,000 | $9.70M | 2.7% | History |
| PFEPfizer Inc | Stock | 215,000 | $5.97M | 1.7% | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 599,460 | $5.20M | 1.4% | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 100,617 | $3.95M | 1.1% | History |
| BBSIBarrett Business Services Inc | COM | 24,000 | $3.04M | 0.8% | History |
| PCRXPacira BioSciences, Inc. | COM | 94,362 | $2.76M | 0.8% | History |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $910.0K | 0.3% | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 25,000 | $731.0K | 0.2% | History |
| ABSIAbsci Corp | COM | 25,000 | $142.0K | <0.1% | History |